The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - BostonGene
Leadership - BostonGene
Stock and Other Ownership Interests - BostonGene
Consulting or Advisory Role - Celgene; Gilead Sciences; Roche
Research Funding - Celgene; Gilead Sciences; Roche
RNA sequencing as a confirmatory assay and its impact on patient care in multiple cancer types.
 
Pashtoon Murtaza Kasi
Stock and Other Ownership Interests - Elicio Therapeutics
Consulting or Advisory Role - Bayer; BostonGene; BostonGene; Daiichi Sankyo/Astra Zeneca; Delcath Systems; Eisai; Elicio Therapeutics; Exact Sciences; Foundation Medicine; Illumina; Ipsen (Inst); Lilly; MSD Oncology; Natera; NeoGenomics Laboratories; QED Therapeutics; SAGA Diagnostics; Seagen; SERVIER; Taiho Oncology; Taiho Pharmaceutical (Inst); Tempus
Research Funding - Advanced Accelerator Applications (Inst); Boston Scientific (Inst); Tersera (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Sofia Smirnova
Employment - BostonGene
Stock and Other Ownership Interests - BostonGene
 
Vladislav Nikulin
Employment - BostonGene
Stock and Other Ownership Interests - BostonGene
 
Jessica H. Brown
Employment - BostonGene
Stock and Other Ownership Interests - BostonGene
 
Nava Almog
Employment - BostonGene
Stock and Other Ownership Interests - BostonGene
 
Anna Ogloblina
Employment - BostonGene
Stock and Other Ownership Interests - BostonGene
 
Clinton Yam
Research Funding - Amgen (Inst); GlaxoSmithKline (Inst); Merck (Inst)
 
Julio Antonio Peguero
Employment - Oncology Consultants
Leadership - Oncology Consultants
Stock and Other Ownership Interests - Oncology Consultants; Roche; Spectrum Pharmaceuticals; Tersera; zogen
Honoraria - Agendia; Guardant Health; Tempus
Speakers' Bureau - Guardant Health; Tempus
Research Funding - Abbvie (Inst); Amgen (Inst); Astellas Pharma (Inst); Bavarian Nordic (Inst); BerGenBio (Inst); Boehringer Ingelheim (Inst); Calithera Biosciences (Inst); Dizal Pharma (Inst); eFFECTOR Therapeutics (Inst); EMD Serono (Inst); Epizyme (Inst); Genentech/Roche (Inst); Immatics (Inst); ImmunityBio (Inst); Immutep (Inst); IncMed (Inst); Incyte (Inst); Ipsen (Inst); Janssen (Inst); Kechow Pharma (Inst); Lilly (Inst); Loxo/Lilly (Inst); Macrogenics (Inst); Mirati Therapeutics (Inst); Natera (Inst); Novartis (Inst); NovoCure (Inst); Sermonix Pharmaceuticals (Inst); Tersera (Inst); Thrive Earlier Detection Corp (Inst); Turning Point Therapeutics (Inst)
Travel, Accommodations, Expenses - Guardant Health; Tempus
 
Devesh Mahesh Pandya
Employment - Oncology Consultants
Leadership - Oncology Consultants
Stock and Other Ownership Interests - Oncology Consultants
Consulting or Advisory Role - Biotheranostics; Boehringer Ingelheim; BostonGene; Curio Science; Puma Biotechnology
Speakers' Bureau - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; EMD Serono; Gilead Sciences; GlaxoSmithKline; Guardant Health; Janssen; Karyopharm Therapeutics; Myriad Genetics; Natera; Pfizer
Research Funding - Abbvie (Inst); Amgen (Inst); Astellas Pharma (Inst); Atreca (Inst); BeiGene (Inst); BerGenBio (Inst); Boehringer Ingelheim (Inst); Calithera Biosciences (Inst); Dizal Pharma (Inst); eFFECTOR Therapeutics (Inst); EMD Serono (Inst); Epizyme (Inst); Freenome (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Immatics (Inst); ImmunityBio (Inst); Immutep (Inst); Incyte (Inst); Ipsen (Inst); Janssen (Inst); Jounce Therapeutics (Inst); Kechow Pharma (Inst); Lilly O. (Inst); Loxo (Inst); MacroGenics (Inst); Mirati Therapeutics (Inst); Molecular Templates (Inst); Natera (Inst); Novocure (Inst); OncoC4 (Inst); OncoMed (Inst); Pfizer (Inst); Qsam (Inst); Regeneron (Inst); Salarius Pharmaceuticals (Inst); Seagen (Inst); Sermonix Pharmaceuticals (Inst); Veloxis (Inst)
 
Daniel Kerr
Employment - Advanced Cancer Treatment Center
Consulting or Advisory Role - Bristol Myers Squibb Foundation; Genentech; Lilly O.
Speakers' Bureau - BeiGene
Travel, Accommodations, Expenses - BeiGene
 
Nathan Fowler
No Relationships to Disclose